Lannett Co Inc (LCI) Social Stream
LANNETT CO INC (LCI) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering LANNETT CO INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 20 months, LCI's average price target has gone down $1.75.
LCI reports an average of 296.95% for its upside potential over the past 39 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
LCI Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 39 weeks, LCI's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- LANNETT CO INC's variance in analysts' estimates is lower than just about 100% of all US stocks.
- LANNETT CO INC's number of analysts covering the stock is higher than 12.6% of stocks in the mid market cap category.
- In terms of how LANNETT CO INC fares relative to stocks in the mid market cap category, note that its average analyst price target is greater than 16.31% of that group.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, LANNETT CO INC's upside potential (average analyst target price relative to current price) is greater than 522.79% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to LANNETT CO INC are ADCT, LEGN, and AMTI.
View All Top Stocks by Price Target
Is LCI a Buy, Hold or Sell? See the POWR Ratings now!